Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Galinpepimut-S |
Trade Name | |
Synonyms | SLS-001|SLS001|SLS 001 |
Drug Descriptions |
Galinpepimut-S (SLS-001) is a WT1 vaccine comprised of four WT1 peptides, which may result in a CD4 and CD8 T cell immune response against WT1-expressing tumor cells (PMID: 28972039, PMID: 29386195). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C161778 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Galinpepimut-S | Galinpepimut-S | 0 | 2 |
Galinpepimut-S + Nivolumab + Sargramostim | Galinpepimut-S Nivolumab Sargramostim | 0 | 1 |
Galinpepimut-S + Pembrolizumab | Galinpepimut-S Pembrolizumab | 0 | 1 |